|
| |
Alfacell CorporationAlfacell Corporation is a biopharmaceutical company primarily engaged in the discovery and development of a new class of anti-cancer drugs from amphibian ribonucleases ("RNases"). RNases degrade ribonucleic acids ("RNA") causing an interruption in protein synthesis resulting in inhibition of cell growth and induction of apoptosis (programmed cell death). The Company's first product under development is ONCONASE(R) which targets solid tumors, most of which are known to become resistant to other chemotherapeutic drugs.
| Contact Details: |
| 225 Belleville Avenue |
| Bloomfield |
| |
| 07003 |
| United States of America |
| Tel: | 973 748 8082 |
| Fax: | 973 748 1355 |
| Email: | info@alfacell.com |
| WWW: | www.alfacell.com/
|
| |
Recent Publications by Alfacell Corporation: |  |
Effect of Onconase on double-stranded RNA in vitro.
Onconase is a cytotoxic ribonuclease which targets tumor cells in vivo and... | 3rd July, 2009
| Alfacell Corporation, Somerset, New Jersey 08873, USA.
| Anticancer Res. 2009 Apr;29(4):1067-71.
|
Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.
Rana pipiens oocytes contain two homologues of pancreatic ribonuclease A... | 28th October, 2008
| Alfacell Corporation, 300 Atrium Drive, Somerset, NJ 08873, USA.
| Curr Pharm Biotechnol. 2008 Jun;9(3):215-25.
|
Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stress.
Onconase (ONC), an antitumor ribonuclease from oocytes of a frog Rana... | 6th December, 2007
| Alfacell Corporation,
| Int J Oncol. 2007 Sep;31(3):663-9.
|
Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P-30 protein, a novel protein possessing anti-tumor activity.
P-30 protein, a novel protein isolated in our laboratory from fertilized... | 1st June, 2000
| Alfacell Corporation, Bloomfield, New Jersey 07003.
| Cell Tissue Kinet. 1990 May;23(3):237-46.
|
Press Releases on Alfacell Corporation:
|
 |
| Alfacell Provides Shareholder Update |
19th June, 2009 |
Alfacell Corporation |
SOMERSET, N.J., June 19 /PRNewswire-FirstCall/ --
Dear Shareholder,
I am grateful to have this opportunity to share with you important developments taking place at this critical juncture in our
|
| Alfacell Announces Receipt of NASDAQ Panel Decision |
5th January, 2009 |
Alfacell Corporation |
SOMERSET, N.J., Jan. 5 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that it received notification on January 2, 2009 that the NASDAQ Listing Qualifications Panel has
|
| Alfacell Provides ONCONASE(R) NDA Submission Update |
5th December, 2008 |
Alfacell Corporation |
SOMERSET, N.J., Dec. 5 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today reported that the U.S. Food and Drug Administration (FDA) has scheduled a pre-NDA meeting date at the end of
|
| Alfacell Receives Going Concern Audit Opinion |
23rd October, 2008 |
Alfacell Corporation |
SOMERSET, N.J., Oct. 23 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that its Annual Report on Form 10-K for the fiscal year ended July 31, 2008, filed with the
|
| Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results |
14th October, 2008 |
Alfacell Corporation |
SOMERSET, N.J., Oct. 14 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today reported its financial results for the fourth quarter and fiscal year ended July 31, 2008.
The company
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 329 times since April 2007, the link to the organisation's website has been followed 51 times Search for more companies in Bloomfield Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Alfacell Corporation |
